Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on October 7, 2026

Oct. 7, 2026

Childhood cancer treatment success reaches 87%, says Medicana specialist

Indeterminate GlobeNewswire

Oct. 7, 2026

NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer

Indeterminate GlobeNewswire

Oct. 7, 2026

AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays

Indeterminate GlobeNewswire

Oct. 7, 2026

Maris-Tech to Showcase Advanced Edge Video & AI Solutions for Armored Vehicles and Unmanned Platforms at the Premier Land Power Expo in North America, AUSA 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program

Indeterminate GlobeNewswire

Oct. 7, 2026

Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA

Indeterminate GlobeNewswire

Oct. 7, 2026

Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications

Indeterminate GlobeNewswire

Oct. 7, 2026

RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial

Indeterminate GlobeNewswire

Oct. 7, 2026

Theialife Announces Positive Type C Meeting with FDA for ND10 in Progressive Myopia

Indeterminate GlobeNewswire

Oct. 7, 2026

Skyharbour Commences Drilling at the Getty East Uranium Joint Venture with Partner Denison Mines at the Russell Lake Project Area

Indeterminate GlobeNewswire

Oct. 7, 2026

Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

Oct. 7, 2026

AMLM Announces Conversion of Worldwide Diversified Holdings, Inc. Note into Common Shares, Strengthening Balance Sheet and Expanding Shareholder Base

Indeterminate GlobeNewswire

Oct. 7, 2026

Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease

Indeterminate GlobeNewswire

Oct. 7, 2026

Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud

Indeterminate GlobeNewswire

Oct. 7, 2026

Gilat Secures Over $10 Million in Additional SkyEdge IV Orders from a Leading Satellite Operator

Indeterminate GlobeNewswire

Oct. 7, 2026

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Indeterminate GlobeNewswire

Oct. 7, 2026

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

Indeterminate GlobeNewswire

Oct. 7, 2026

Redevances OR annonce ses livraisons préliminaires d’OEO pour le troisième trimestre de 2026

Indeterminate GlobeNewswire